Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Visionstate Announces Deals in Canada and the US, Highlights Growing Opportunities (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Vaccinex Inc VCNX

Healthcare Biotechnology
Vaccinex, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including neurodegenerative diseases, cancer, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical development for the treatment of Alzheimer’s disease, head and... see more

Current News (OTCPK:VCNX)

Vaccinex Announces Receipt of Delisting Notification from Nasdaq

GlobeNewswire December 17, 2024

Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire November 18, 2024

Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC

GlobeNewswire November 7, 2024

Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer's Annual Meeting

GlobeNewswire November 5, 2024

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer's Disease (CTAD) Conference in Madrid, Spain

GlobeNewswire October 31, 2024

Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer's Disease (CTAD) Conference on October 31, 2024

GlobeNewswire October 24, 2024

Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds

GlobeNewswire September 18, 2024

Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer's Disease and Plans to Pursue a Development Partnership

GlobeNewswire August 14, 2024

Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer's Disease

GlobeNewswire July 31, 2024
View More News ››

Opinion & Analysis (OTCPK:VCNX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCPK:VCNX)

Vaccinex Announces Receipt of Delisting Notification from Na

BREAKING NEWS: $VCNX Vaccinex Announces Receipt of Delisting Notification from NasdaqROCHESTER, N.Y., Dec. 17, 2024 (GLOBE NEWSWIRE...
whytestocks - December 17, 2024

Vaccinex Provides Update on New Findings for SIGNAL-AD Phase

News; $VCNX Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer's Disease and Plans to...
whytestocks - August 14, 2024

(VCNX) Trading Advice

News; $VCNX (VCNX) Trading Advice2024-03-08 11:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method....
whytestocks - March 8, 2024
View more Bullboard ››

Lithium Ionic Corp

Lithium Ionic Corp

Lithium Ionic Corp. is a Canadian mining company. The Company is engaged exploring and developing its lithium properties in ...
View More »